rxstat › Classes › Potassium-sparing Agents
Potassium-sparing Agents: shortage status in Canada
3 of the 3 potassium-sparing agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Spironolactone (Aldactone) Widespread shortage 4 of 8 reported products affected · est. return Oct 23, 2026
Amiloride (Midamor) Partial shortage 1 of 1 reported products affected · est. return Nov 13, 2026
Eplerenone (Inspra) Partial shortage 1 of 4 reported products affected · est. return Jan 22, 2027
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.